MENU
PVLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Palvella Therapeutics (PVLA) Ownership - Who owns Palvella Therapeutics?
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
554.42M
P/E Ratio
14.22
Total Cash
70.43M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PVLA
Capitalization
554M
P/E Ratio
14.22
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
70.4M
Total Cash/Share
6.37
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
47.8M
P/B Ratio
11.60
Cash Flow
N/A
Earnings
-2.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
7.67
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-23.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.96
Shares Held By Institutions
121M
Shares Outstanding - Current
11.1M
Total Liabilities
26M
Total Volume MTD
N/A
Value
-1
Gain YTD
317.750
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information